Altasciences
Laval, Canada
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Altasciences
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Laval, Canada
- Modalities
- Small Molecule (Oral Solid Dose), Capsules (liquid-filled, gelatin, hypromellose), HPAPI / High-Potency API, Formulation Development, Analytical & Stability Testing, Clinical Trial Material Manufacturing, Phase I–Commercial Scale Manufacturing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Altasciences
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose), Capsules (liquid-filled, gelatin, hypromellose), HPAPI / High-Potency API, Formulation Development, Analytical & Stability Testing, Clinical Trial Material Manufacturing, Phase I–Commercial Scale Manufacturing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
Altasciences Announces Chris Perkin Appointed Executive Chairman; Marie-Hélène Raigneau Appointed Chief Executive Officer - Business Wire
Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Business Wire
PA-ALTASCIENCES - Voice of Alexandria
Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Via Ritzau
Altasciences achève l’agrandissement de son laboratoire de recherche et développement à Harleysville, en Pennsylvanie - New Castle News
Altasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Eagle-Tribune
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development - Business Wire
Flipping the drug development industry on its head - Reuters
Pharmaceutical research on mRNA and CAR T-cell therapy in cancer: Pioneering the future of oncology - BioPharma Dive
Altasciences Expands Its Harleysville, PA Lab, Betting That Connection Beats Scale in Drug Development Outsourcing - BioBuzz
Frequently Asked Questions About Altasciences
What is Altasciences's CDMO Signal Score?
Altasciences has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Altasciences for a manufacturing program?
Use the free AI matchmaker to compare Altasciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pyramid Pharma Services (Pyramid Laboratories, Inc.)
Costa Mesa, CA
Biologics, Sterile Injectables / Aseptic Fill-Finish, Lyophilization, Peptides, Small Molecules, siRNA/Oligonucleotide Injectable, Formulation Development, Analytical & Stability Testing
VerGo Pharma Research Laboratories Pvt. Ltd.
Verna, Goa, India
Small Molecule (Oral Solid Dose), API Process Development, Formulation Development, Analytical Development, HPAPI / Cytotoxic, Clinical Batch Manufacturing, cGMP Commercial Manufacturing, Custom Synthesis, ICH Stability Studies, Bioequivalence / Bioavailability (BA/BE) Studies
Quotient Sciences
Nottingham, United Kingdom
Small Molecule (Oral Solid Dose), HPAPI / High-Potency API, Modified Release, Pediatric Formulation, Oral Peptide, Solubility Enhancement (SDD, HME, Nanoparticulate), Clinical Pharmacology (Phase I CRO)
MedPharm (Tergus Pharma)
Guildford UK, Durham NC
Signal Score: 80.8
Topical CDMO, Topical Drug Product Development, Transepithelial Drug Delivery, Formulation Development, Analytical Method Development, Analytical Testing, IVRT, IVPT, Human-Relevant In Vitro Models, Semisolid GMP Manufacturing, GMP Clinical Trial Material Manufacturing, GMP Commercial Manufacturing, Stability Studies, Transdermal Drug Delivery, Nasal Drug Delivery, Respiratory Drug Delivery, Ocular Drug Delivery, Nail Drug Delivery, Creams, Gels, Ointments, Lotions
Serán Bioscience
Bend, OR
Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)